Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
CareCloud Leadership to Discuss Use of Generative AI in Healthcare
-
Syntec Optics (Nasdaq: OPTX) to Participate in the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference
-
Innovative Eyewear, Inc. to Participate in "Charting the Course: Navigating the Intersection of TMT and Business in the AI Era" Conference, June 4 - 5, 2024
-
Amplitech Group Inc. (AMPG) PT Lowered to $6 at Maxim Group
-
Mobilicom CEO Oren Elkayam to Participate in Fireside Chat at the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference, presented by Maxim Group LLC, on
-
Emerald to Participate in Maxim Group TMT Conference
-
Identity and Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9:00am ET
-
Jet.AI to Present at the Maxim Group Virtual TMT Conference on Tuesday, June 4, 2024
-
Inuvo CEO to Participate in Fireside Chat at the Maxim Group TMT Conference on June 5, 2024
-
AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering
-
Draganfly to Participate in the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference, Presented by Maxim Group LLC
-
B2i Digital Sponsors and Provides Marketing Support for Maxim Group's Virtual Conference: "Charting the Course: Navigating the Intersection of TMT and Business in the AI Era"
-
B2i Digital Sponsors and Provides Marketing Support for Maxim Group's Virtual Conference: "Charting the Course: Navigating the Intersection of TMT and Business in the AI Era"
-
Dolphin Entertainment to Participate in Maxim Group's Virtual Investor Conference on June 4, 2024, at 11:00am ET
-
Super League CEO, Ann Hand, to Participate in Maxim Group Virtual Fireside Chat on the Marketing Channel of the Future, Leading Global Brands into 3D Immersive Platforms
-
BEN to Present at Upcoming Investor Conference
-
Maxim Group Continues Growth in its Institutional Sales and Trading Division with Hiring of John Novak
-
LeddarTech Announces Participation in the Maxim Group Virtual TMT Conference on June 4, 2024 and the Deutsche Bank Global Auto Industry Conference on June 11-12, 2024 in New York, NY
-
Euroseas Ltd. (ESEA) PT Raised to $52 at Maxim Group
-
Roadzen to Participate in Fireside Chat at the Maxim Group TMT Conference on June 4, 2024
-
Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study
-
Edible Garden (EDBL) Announces Pricing of $6.0 Million Public Offering
-
Edible Garden Announces Pricing of $6.0 Million Public Offering
-
B2i Digital Provides Marketing Support and Sponsors the Prestigious 10th Annual ROTH London Conference
-
B2i Digital Provides Marketing Support and Sponsors the Prestigious 10th Annual ROTH London Conference
-
ClimateRock (CLRC) Appoints Dariusz Sliwinski to the Board of Directors
-
ClimateRock Appoints Dariusz Sliwinski to the Board of Directors
-
Iteris to Participate in Fireside Chat at the Maxim Group TMT Conference on June 4, 2024
-
MGO Global Announces First Quarter 2024 Results
-
Inhibikase Therapeutics (IKT) Prices 1.67M Share and Warrant Offering at $1.68/sh
-
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $4.0 Million
-
Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study
-
Virios Therapeutics (VIRI) Announces $2.1M Share Offering, Commences Preparations for Planned IMC-2 Long-COVID Phase 2b Study
-
Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study
-
Alternus Clean Energy Partners with B2i Digital to Execute a Comprehensive Investor Communication and Education Initiative
-
Alternus Clean Energy Partners with B2i Digital to Execute a Comprehensive Investor Communication and Education Initiative
-
Tivic Reports First Quarter 2024 Financial Results and Subsequent Events
-
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
-
Aethlon Medical (AEMD) Prices 8.1M Share Offering at $0.58/sh
-
Aethlon Medical Announces Pricing of $4.7 Million Public Offering
-
GreenPower to Showcase its Safe, Sensible and Sustainable Expanding Transportation Solutions at ACT Expo 2024
-
Draganfly Announces First Quarter Results of 2024
-
Tivic Health Announces Closing of $4.0 Million Public Offering
-
Maxim Group Downgrades Applied DNA Sciences (APDN) to Hold (correction)
-
Maxim Group Promotes Michael A. Cerussi to Head of Institutional Sales and Trading
-
GreenPower Announces Closing of US$2.3 Million Underwritten Public Offering
-
B2i Digital is a Marketing Partner for The Reg A & Crowdfunding Conference and The SPAC Conference in Westchester County, NY
-
B2i Digital is a Marketing Partner for The Reg A & Crowdfunding Conference and The SPAC Conference in Westchester County, NY
-
Tivic Health Systems (TIVC) Prices 4.71M Share Offering at $0.85/sh
-
Tivic Health Announces Pricing of $4.0 Million Public Offering

